{"transactions":[{"id":752509,"issuer":{"id":6721,"kind":"organization","name":"ONCOLYTICS BIOTECH INC"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2026-06-03T20:30:44.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Capital Market on the date of grant, June 1, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments with the first tranche vesting on June 1, 2027, subject to the Reporting Person's continued service or employment, as applicable, on each such vesting date."}],"balance_after":30000,"derivative":{"exercise_price":1.06,"expiration_date":"2036-06-01","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001493152-26-027097","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1129928/000149315226027097/ownership.xml","form_type":"4"}},{"id":3622830,"issuer":{"id":134906,"kind":"organization","name":"XERIS PHARMACEUTICALS INC","symbol":"XERS"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-03-01T16:35:36.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of these shares shall vest on the first anniversary of the vesting commencement date, with the remainder vesting ratably over the following 36 months."}],"balance_after":20000,"derivative":{"exercise_price":10,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-19-005457","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346302/000089924319005457/doc4.xml","form_type":"4"}},{"id":3827062,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-09-04T19:40:32.000Z","date":"2018-08-30","kind":"other","acquired":false,"shares":163394,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  At the Effective Time, each outstanding in-the-money option, whether vested or unvested, was converted into the right to receive (1) a cash payment equal to (x) the excess, if any, of $4.46 over the exercise price payable under such option, multiplied by (y) the total number of shares subject to such option immediately prior to the Effective Time and (2) a number of CVRs equal to the total number of shares subject to such option immediately prior to the Effective Time."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  At the Effective Time, each outstanding in-the-money option, whether vested or unvested, was converted into the right to receive (1) a cash payment equal to (x) the excess, if any, of $4.46 over the exercise price payable under such option, multiplied by (y) the total number of shares subject to such option immediately prior to the Effective Time and (2) a number of CVRs equal to the total number of shares subject to such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":3.65,"expiration_date":"2027-12-28","underlying":"Ordinary Shares","underlying_shares":163394},"source":{"system":"sec-edgar","filing":"0001209191-18-049375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000120919118049375/doc4.xml","form_type":"4"}},{"id":3827061,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-09-04T19:40:32.000Z","date":"2018-08-30","kind":"other","acquired":false,"shares":63764,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  At the Effective Time, each outstanding in-the-money option, whether vested or unvested, was converted into the right to receive (1) a cash payment equal to (x) the excess, if any, of $4.46 over the exercise price payable under such option, multiplied by (y) the total number of shares subject to such option immediately prior to the Effective Time and (2) a number of CVRs equal to the total number of shares subject to such option immediately prior to the Effective Time."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  At the Effective Time, each outstanding in-the-money option, whether vested or unvested, was converted into the right to receive (1) a cash payment equal to (x) the excess, if any, of $4.46 over the exercise price payable under such option, multiplied by (y) the total number of shares subject to such option immediately prior to the Effective Time and (2) a number of CVRs equal to the total number of shares subject to such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":2.74,"expiration_date":"2026-06-17","underlying":"Ordinary Shares","underlying_shares":63764},"source":{"system":"sec-edgar","filing":"0001209191-18-049375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000120919118049375/doc4.xml","form_type":"4"}},{"id":3827060,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-09-04T19:40:32.000Z","date":"2018-08-30","kind":"other","acquired":false,"shares":131451,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  At the Effective Time, each outstanding out-of-the-money option, whether vested or unvested, was converted into the right to receive a cash payment, if and when the Milestone is achieved, equal to (x) the excess, if any, of the sum of (1) $4.46 and (2) the contingent consideration actually payable per CVR over the exercise price payable under such option, multiplied by (y) the total number of shares subject to such option immediately prior to the Effective Time"},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  At the Effective Time, each outstanding out-of-the-money option, whether vested or unvested, was converted into the right to receive a cash payment, if and when the Milestone is achieved, equal to (x) the excess, if any, of the sum of (1) $4.46 and (2) the contingent consideration actually payable per CVR over the exercise price payable under such option, multiplied by (y) the total number of shares subject to such option immediately prior to the Effective Time"}],"balance_after":0,"derivative":{"exercise_price":5.84,"expiration_date":"2022-01-25","underlying":"Ordinary Shares","underlying_shares":131451},"source":{"system":"sec-edgar","filing":"0001209191-18-049375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000120919118049375/doc4.xml","form_type":"4"}},{"id":3827059,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-09-04T19:40:32.000Z","date":"2018-08-30","kind":"other","acquired":false,"shares":145212,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  At the Effective Time, each outstanding in-the-money option, whether vested or unvested, was converted into the right to receive (1) a cash payment equal to (x) the excess, if any, of $4.46 over the exercise price payable under such option, multiplied by (y) the total number of shares subject to such option immediately prior to the Effective Time and (2) a number of CVRs equal to the total number of shares subject to such option immediately prior to the Effective Time."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  At the Effective Time, each outstanding in-the-money option, whether vested or unvested, was converted into the right to receive (1) a cash payment equal to (x) the excess, if any, of $4.46 over the exercise price payable under such option, multiplied by (y) the total number of shares subject to such option immediately prior to the Effective Time and (2) a number of CVRs equal to the total number of shares subject to such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":3.61,"expiration_date":"2021-07-07","underlying":"Ordinary Shares","underlying_shares":145212},"source":{"system":"sec-edgar","filing":"0001209191-18-049375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000120919118049375/doc4.xml","form_type":"4"}},{"id":3827058,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-09-04T19:40:32.000Z","date":"2018-08-30","kind":"other","acquired":false,"shares":18515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  At the Effective Time, each outstanding in-the-money option, whether vested or unvested, was converted into the right to receive (1) a cash payment equal to (x) the excess, if any, of $4.46 over the exercise price payable under such option, multiplied by (y) the total number of shares subject to such option immediately prior to the Effective Time and (2) a number of CVRs equal to the total number of shares subject to such option immediately prior to the Effective Time."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  At the Effective Time, each outstanding in-the-money option, whether vested or unvested, was converted into the right to receive (1) a cash payment equal to (x) the excess, if any, of $4.46 over the exercise price payable under such option, multiplied by (y) the total number of shares subject to such option immediately prior to the Effective Time and (2) a number of CVRs equal to the total number of shares subject to such option immediately prior to the Effective Time."}],"balance_after":0,"derivative":{"exercise_price":3.61,"expiration_date":"2020-05-01","underlying":"Ordinary Shares","underlying_shares":18515},"source":{"system":"sec-edgar","filing":"0001209191-18-049375","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000120919118049375/doc4.xml","form_type":"4"}},{"id":3827057,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-09-04T19:40:32.000Z","date":"2018-08-30","kind":"sale","acquired":false,"shares":4960,"price":4.46,"value":22121.6,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  Under the Merger Agreement, at the effective time of the merger (the \"Effective Time\"), each outstanding ordinary share of the Issuer was converted into the right to receive (1) $4.46 in cash plus (2) one contractual contingent value right (a \"CVR\"), which represents the right to receive $2.63 in cash upon the achievement of a specified milestone (the \"Milestone\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  Under the Merger Agreement, at the effective time of the merger (the \"Effective Time\"), each outstanding ordinary share of the Issuer was converted into the right to receive (1) $4.46 in cash plus (2) one contractual contingent value right (a \"CVR\"), which represents the right to receive $2.63 in cash upon the achievement of a specified milestone (the \"Milestone\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-049375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000120919118049375/doc4.xml","form_type":"4"}},{"id":3827056,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-09-04T19:40:32.000Z","date":"2018-08-30","kind":"sale","acquired":false,"shares":41605,"price":4.46,"value":185558.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  Under the Merger Agreement, at the effective time of the merger (the \"Effective Time\"), each outstanding ordinary share of the Issuer was converted into the right to receive (1) $4.46 in cash plus (2) one contractual contingent value right (a \"CVR\"), which represents the right to receive $2.63 in cash upon the achievement of a specified milestone (the \"Milestone\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger, dated as of April 29, 2018, by and among United Therapeutics Corporation (\"United\"), Daniel 24043 Acquisition Corp., a wholly-owned subsidiary of United, and the Issuer (the \"Merger Agreement\").  Under the Merger Agreement, at the effective time of the merger (the \"Effective Time\"), each outstanding ordinary share of the Issuer was converted into the right to receive (1) $4.46 in cash plus (2) one contractual contingent value right (a \"CVR\"), which represents the right to receive $2.63 in cash upon the achievement of a specified milestone (the \"Milestone\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-18-049375","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000120919118049375/doc4.xml","form_type":"4"}},{"id":3832516,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-08-27T16:07:18.000Z","date":"2018-08-24","kind":"exercise","acquired":false,"shares":16994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33% of the Option Shares shall vest on the one-year anniversary of the grant date. Thereafter, the remainder of the Option Shares shall vest in 8 equal amounts every 3 months beginning 3 months after the one-year anniversary date."}],"balance_after":22097,"derivative":{"exercise_price":2.74,"expiration_date":"2026-06-17","underlying":"Ordinary Shares","underlying_shares":16994},"source":{"system":"sec-edgar","filing":"0001562180-18-003770","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000156218018003770/primarydocument.xml","form_type":"4"}},{"id":3832515,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2018-08-27T16:07:18.000Z","date":"2018-08-23","kind":"exercise","acquired":false,"shares":44242,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33% of the Option Shares shall vest on the one-year anniversary of the grant date. Thereafter, the remainder of the Option Shares shall vest in 8 equal amounts every 3 months beginning 3 months after the one-year anniversary date."}],"balance_after":39091,"derivative":{"exercise_price":2.74,"expiration_date":"2026-06-17","underlying":"Ordinary Shares","underlying_shares":44242},"source":{"system":"sec-edgar","filing":"0001562180-18-003770","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000156218018003770/primarydocument.xml","form_type":"4"}},{"id":3832514,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-08-27T16:07:18.000Z","date":"2018-08-24","kind":"sale","acquired":false,"shares":16994,"price":4.7,"value":79871.8,"ownership":{"direct":true},"balance_after":41605,"source":{"system":"sec-edgar","filing":"0001562180-18-003770","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000156218018003770/primarydocument.xml","form_type":"4"}},{"id":3832513,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-08-27T16:07:18.000Z","date":"2018-08-24","kind":"exercise","acquired":true,"shares":16994,"price":2.74,"value":46563.56,"ownership":{"direct":true},"balance_after":58599,"source":{"system":"sec-edgar","filing":"0001562180-18-003770","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000156218018003770/primarydocument.xml","form_type":"4"}},{"id":3832512,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-08-27T16:07:18.000Z","date":"2018-08-23","kind":"sale","acquired":false,"shares":44242,"price":4.7289,"value":209215.9938,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average price with a low of $4.70 and a high of $4.775."}],"balance_after":41605,"source":{"system":"sec-edgar","filing":"0001562180-18-003770","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000156218018003770/primarydocument.xml","form_type":"4"}},{"id":3832511,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-08-27T16:07:18.000Z","date":"2018-08-23","kind":"exercise","acquired":true,"shares":44242,"price":2.74,"value":121223.08,"ownership":{"direct":true},"balance_after":85847,"source":{"system":"sec-edgar","filing":"0001562180-18-003770","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000156218018003770/primarydocument.xml","form_type":"4"}},{"id":3839544,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-08-17T16:05:42.000Z","date":"2018-08-17","kind":"sale","acquired":false,"shares":88831,"price":4.6576,"value":413739.2656,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price represents the weighted average price with a low of $4.65 and a high of $4.70."}],"balance_after":41605,"source":{"system":"sec-edgar","filing":"0001562180-18-003675","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000156218018003675/primarydocument.xml","form_type":"4"}},{"id":3847128,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Rt to Buy)","published_at":"2018-08-10T16:22:45.000Z","date":"2018-08-09","kind":"exercise","acquired":false,"shares":88831,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.61,"expiration_date":"2018-08-11","underlying":"Ordinary Shares","underlying_shares":88831},"source":{"system":"sec-edgar","filing":"0001209191-18-046227","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000120919118046227/doc4.xml","form_type":"4"}},{"id":3847127,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-08-10T16:22:45.000Z","date":"2018-08-09","kind":"exercise","acquired":true,"shares":88831,"price":3.61,"value":320679.91,"ownership":{"direct":true},"balance_after":130436,"source":{"system":"sec-edgar","filing":"0001209191-18-046227","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000120919118046227/doc4.xml","form_type":"4"}},{"id":3874260,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-07-03T14:39:59.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":4961,"price":4.5,"value":22324.5,"ownership":{"direct":false,"nature":"By spouse"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales are pursuant to a 10b5-1 Plan."}],"balance_after":4960,"source":{"system":"sec-edgar","filing":"0001104659-18-043808","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000110465918043808/a4.xml","form_type":"4"}},{"id":3874259,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2018-07-03T14:39:59.000Z","date":"2018-07-02","kind":"sale","acquired":false,"shares":41605,"price":4.5,"value":187222.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sales are pursuant to a 10b5-1 Plan."}],"balance_after":41605,"source":{"system":"sec-edgar","filing":"0001104659-18-043808","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000110465918043808/a4.xml","form_type":"4"}},{"id":4120024,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2017-12-28T15:31:04.000Z","date":"2017-12-28","kind":"grant","acquired":true,"shares":163394,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"1/3rd of the Option Shares shall vest on the first anniversary of the grant date.  Thereafter, the remaining balance of the Option Shares shall vest in a series of 8 equal consecutive quarterly installments until fully vested."}],"balance_after":163394,"derivative":{"exercise_price":3.65,"expiration_date":"2027-12-28","underlying":"Ordinary Shares","underlying_shares":163394},"source":{"system":"sec-edgar","filing":"0001209191-17-067564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000120919117067564/doc4.xml","form_type":"4"}},{"id":4120023,"issuer":{"id":163743,"kind":"organization","name":"SteadyMed Ltd.","symbol":"STDY"},"owners":[{"id":41899,"kind":"person","name":"RIGBY JONATHAN","position":1,"cik":"0001356227","reported_name":"RIGBY JONATHAN","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Ordinary Shares","published_at":"2017-12-28T15:31:04.000Z","date":"2017-12-28","kind":"grant","acquired":true,"shares":83210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of SteadyMed Ltd. ordinary shares."},{"field":"shares","element":"transactionShares","label":"F2","text":"The restricted stock units (\"RSUs\")are 50% time-based and 50% performance based grants.  50% of the RSUs shall vest on June 30, 2018 and 50% shall vest upon approval by the FDA of the New Drug Application for Trevyent."}],"balance_after":83210,"source":{"system":"sec-edgar","filing":"0001209191-17-067564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1356227/000120919117067564/doc4.xml","form_type":"4"}}]}